Ingo Müller

University Medical Center Hamburg-Eppendorf

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (18)

Collaborators (8)

Halvard Bonig

Marianne Ifversen

Head of cellular therapies and immune defeiciency

Rigshospitalet

Olaf Penack

Michaela Döring

Andrea Jarisch

University Hospital

Boris Fehse

Universitätsklinikum Hamburg-Eppendorf

Karin Melanie Cabanillas Stanchi

Lucia Laugwitz

University of Tübingen

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ingo Müller

Research Interests

Explore related searches

Contact this professor

Articles (18)

Collaborators (8)

Halvard Bonig

Marianne Ifversen

Olaf Penack

Michaela Döring

Andrea Jarisch

Boris Fehse

Karin Melanie Cabanillas Stanchi

Lucia Laugwitz

Make your next move.

Ingo Müller

Research Interests

Explore related searches

Contact this professor

Articles (18)

Clinical relevance of feto-maternal microchimerism in (hematopoietic stem cell) transplantation

GD2-CAR NK-92 cell activity against neuroblastoma cells is insusceptible to TIGIT knockout.

Genetic Risk Profiling Reveals Altered Glycosyltransferase Expression as a Predictor for Patient Outcome in Neuroblastoma

Case report: Granulocyte-macrophage colony-stimulating factor sargramostim did not rescue the neutrophil phenotype in two patients with JAGN1-mutant severe congenital neutropenia.

Haematopoietic stem cell transplantation after reduced intensity conditioning in children and adolescents with chronic myeloid leukaemia: A prospective multicentre trial of the I-BFM Study Group.

Glycan Structures in Osteosarcoma as Targets for Lectin-Based Chimeric Antigen Receptor Immunotherapy

Finding a balance in reduced toxicity hematopoietic stem cell transplantation for thalassemia: role of infused CD3+ cell count and immunosuppression

Precise CRISPR-Cas9 gene repair in autologous memory T cells to treat familial hemophagocytic lymphohistiocytosis

CD19 CAR T cells are an effective therapy for posttransplant relapse in patients with B-lineage ALL: real-world data from Germany.

MAP kinase activating death domain deficiency is a novel cause of impaired lymphocyte cytotoxicity.

Epigenetic Modification of Mesenchymal Stromal Cells Derived from Bone Marrow and Embryonal Tumors to Facilitate Immunotherapeutic Approaches in Pediatric Malignancies

Hematopoietic Stem Cell Transplantation with Mesenchymal Stromal Cells in Children with Metachromatic Leukodystrophy.

Glyco-binding domain chimeric antigen receptors as a new option for cancer immunotherapy.

Immune Ablation and Stem Cell Rescue in Two Pediatric Patients with Progressive Severe Chronic Graft-Versus-Host Disease

Comparison of single copy gene‑based duplex quantitative PCR and digital droplet PCR for monitoring of expansion of CD19‑directed CAR T cells in treated patients.

Influence of Fetomaternal Microchimerism on Maternal NK Cell Reactivity against the Child&rsquo;s Leukemic Blasts

The Reconstitution Dynamics of Cultivated Hematopoietic Stem Cells and Progenitors Is Independent of Age

NET Release of Long-Term Surviving Neutrophils.

Collaborators (8)

Halvard Bonig

Marianne Ifversen

Olaf Penack

Michaela Döring

Andrea Jarisch

Boris Fehse

Karin Melanie Cabanillas Stanchi

Lucia Laugwitz

Make your next move.

Influence of Fetomaternal Microchimerism on Maternal NK Cell Reactivity against the Child’s Leukemic Blasts